http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Habeeb Ibrahim Abdul Razack,Sam Mathew,Fathinul Fikri Ahmad Saad,Saleh A. Alqahtani 한국과학학술지편집인협의회 2021 Science Editing Vol.8 No.2
The flood of research output and increasing demands for peer reviewers have necessitated the intervention of artificial intelligence (AI) in scholarly publishing. Although human input is seen as essential for writing publications, the contribution of AI slowly and steadily moves ahead. AI may redefine the role of science communication experts in the future and transform the scholarly publishing industry into a technology-driven one. It can prospectively improve the quality of publishable content and identify errors in published content. In this article, we review various AI and other associated tools currently in use or development for a range of publishing obligations and functions that have brought about or can soon leverage much-demanded advances in scholarly communications. Several AI-assisted tools, with diverse scope and scale, have emerged in the scholarly market. AI algorithms develop summaries of scientific publications and convert them into plain-language texts, press statements, and news stories. Retrieval of accurate and sufficient information is prominent in evidence-based science publications. Semantic tools may empower transparent and proficient data extraction tactics. From detecting simple plagiarism errors to predicting the projected citation impact of an unpublished article, AI’s role in scholarly publishing is expected to be multidimensional. AI, natural language processing, and machine learning in scholarly publishing have arrived for writers, editors, authors, and publishers. They should leverage these technologies to enable the fast and accurate dissemination of scientific information to contribute to the betterment of humankind.
Sam T. Mathew,Habeeb Ibrahim Abdul Razack,Prasanth Viswanathan 한국과학학술지편집인협의회 2022 Science Editing Vol.9 No.1
Purpose: This study aimed to develop a decision-support tool to quantitatively determine authorship in clinical trial publications. Methods: The tool was developed in three phases: consolidation of authorship recommendations from the Good Publication Practice (GPP) and International Committee of Medical Journal Editors (ICMJE) guidelines, identifying and scoring attributes using a 5-point Likert scale or a dichotomous scale, and soliciting feedback from editors and researchers. Results: The authorship criteria stipulated by the ICMJE and GPP recommendations were categorized into 2 Modules. Criterion 1 and the related GPP recommendations formed Module 1 (sub-criteria: contribution to design, data generation, and interpretation), while Module 2 was based on criteria 2 to 4 and the related GPP recommendations (sub-criteria: contribution to manuscript preparation and approval). The two modules with relevant sub-criteria were then differentiated into attributes (n = 17 in Module 1, n = 12 in Module 2). An individual contributor can be scored for each sub-criterion by summing the related attribute values; the sum of sub-criteria scores constituted the module score (Module 1 score: 70 [contribution to conception or design of the study, 20; data acquisition, 7; data analysis, 27; interpretation of data, 16]; Module 2 score: 50 [content development, 27; content review, 18; accountability, 5]). The concept was integrated into Microsoft Excel with adequate formulae and macros. A threshold of 50% for each sub-criterion and each module, with an overall score of 65%, is predefined as qualifying for authorship. Conclusion: This authorship decision-support tool would be helpful for clinical trial sponsors to assess and provide authorship to deserving contributors.